Perceptions About the Harm & Addictiveness of Nicotine & Very Low Nicotine

The Food and Drug Administration is forecasting a contract opportunity focused on researching public perceptions regarding the harm and addictiveness of nicotine and very low nicotine content cigarettes in comparison to other tobacco products. This effort aims to understand how consumers perceive the risks and addictive potential of reduced-nicotine cigarettes versus traditional tobacco products, which will inform regulatory decisions and public health messaging. The work will likely involve survey design, data collection, qualitative and quantitative analysis, and reporting on behavioral insights related to nicotine perception across diverse populations. The contract falls under NAICS code 541618, which covers other scientific and technical consulting services, indicating that the task requires specialized expertise in behavioral science, public health communication, or tobacco regulatory research. The opportunity is not yet open for bidding, with a posted date of May 25, 2026, and no solicitation number or set-aside details available. Point of contact for program-related inquiries is the CTP Acquisition Liaison, reachable via ctpacquisitions@fda.hhs.gov, while the contracting officer information is pending. The performance location and organizational set-aside details have not been specified, suggesting the work may be conducted remotely or across multiple sites with flexibility in execution.